Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice
Bahman Rostama, Megan Beauchemin, Celeste Bouchard, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9362-9362
Open Access | Times Cited: 20

Showing 20 citing articles:

Exploring the therapeutic potential of chlorogenic acid in alleviating olanzapine-induced metabolic syndrome in rats: a key role of hypothalamic satiety proteins
Zeinab Ebrahimian, Bibi Marjan Razavi, Seyed Ali Mousavi Shaegh, et al.
Nutritional Neuroscience (2025), pp. 1-20
Closed Access
The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia
Muhammad Youshay Jawad, Shakila Meshkat, Aniqa Tabassum, et al.
CNS Spectrums (2022) Vol. 28, Iss. 5, pp. 541-560
Closed Access | Times Cited: 21
Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
Anwesha Gangopadhyay, Radwa Ibrahim, Karli Theberge, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 20
The Extracellular Matrix Environment of Clear Cell Renal Cell Carcinoma Determines Cancer Associated Fibroblast Growth
Kyle Bond, Takuto Chiba, Kieran P. H. Wynne, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 5873-5873
Open Access | Times Cited: 26
Identification of potential blood biomarkers for early diagnosis of schizophrenia through RNA sequencing analysis
Zhijun Li, Xinwei Li, Mengdi Jin, et al.
Journal of Psychiatric Research (2022) Vol. 147, pp. 39-49
Closed Access | Times Cited: 9
Mechanisms Underlying Antipsychotic-Induced NAFLD and Iron Dysregulation: A Multi-Omic Approach
Meghan May, Deborah Barlow, Radwa Ibrahim, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1225-1225
Open Access | Times Cited: 9
Risk of Nonalcoholic Fatty Liver Disease in Patients With Schizophrenia Treated With Antipsychotic Drugs
Akihiro Koreki, Hiroko Mori, Shoko Nozaki, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 4, pp. 474-477
Closed Access | Times Cited: 12
Elevated risk of liver steatosis in first-episode psychosis patients: Results from a 3-year prospective study
S. Galiano Rus, Víctor Ortiz‐García de la Foz, M. Arias, et al.
Schizophrenia Research (2022) Vol. 246, pp. 30-38
Closed Access | Times Cited: 6
High prevalence of metabolic diseases, liver steatosis and fibrosis among Chinese psychiatric patients
Huixia Li, Chi Chen, Yi Chen, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Macrophage-derived secretome is sufficient to confer olanzapine-mediated insulin resistance in human adipocytes
Priya Dipta, Assel Sarsenbayeva, Miriam Shmuel, et al.
Comprehensive Psychoneuroendocrinology (2021) Vol. 7, pp. 100073-100073
Open Access | Times Cited: 7
The development of the Metabolic-associated Fatty Liver Disease during pharmacotherapy of mental disorders - a review
Jakub Rogalski, Aleksandra Subdys, Oliwia Gawlik-Kotelnicka
Current Problems of Psychiatry (2022) Vol. 23, Iss. 3, pp. 128-143
Open Access | Times Cited: 4
Salsalate and/or metformin therapy confer beneficial metabolic effects in olanzapine treated female mice
Hesham Shamshoum, Kyle D. Medak, Greg L. McKie, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115671-115671
Open Access | Times Cited: 2
Application of the “Method Operable Design Region” (MODR) approach for the development of a UHPLC method for the assay and purity determination of risperidone in risperidone drug substance and other formulations
Amit Pawar, N.N. Pandita
Biomedical Chromatography (2022) Vol. 36, Iss. 10
Closed Access | Times Cited: 3
Olanzapine’s effects on hypothalamic transcriptomics and kinase activity
Sandra Pereira, L Castellani, Chantel Kowalchuk, et al.
Psychoneuroendocrinology (2024) Vol. 163, pp. 106987-106987
Closed Access
From Diabetes to Dementia: Identifying Key Genes in the Progression of Cognitive Impairment
Zhaoming Cao, Yage Du, Guangyi Xu, et al.
Brain Sciences (2024) Vol. 14, Iss. 10, pp. 1035-1035
Open Access
Downregulation of Bmal1 Expression in Celiac Ganglia Protects against Hepatic Ischemia-Reperfusion Injury
Jiarui Feng, Lilong Zhang, Enfu Xue, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 713-713
Open Access | Times Cited: 1
Short-term treatment with risperidone ameliorated 1,2-diacetylbenzene-induced liver dysfunction
Hai Duc Nguyen, Won Hee Jo, Ngoc Hoang, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110687-110687
Closed Access | Times Cited: 1
Deciphering Risperidone-Induced Lipogenesis by Network Pharmacology and Molecular Validation
Yun Fu, Ke Yang, Yepei Huang, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 2
[Bioinformatic analysis of differentially expressed proteins in the dorsal raphe nucleus of rats after continuous treatment with olanzapine].
Peng Huang, Jie Zhu, H Li, et al.
PubMed (2022) Vol. 42, Iss. 8, pp. 1221-1229
Closed Access
Prevalence of non-alcoholic fatty liver disease in pediatric mental disorder inpatients: a tertiary mental health referral hospital study
Lini Liu, Rongrong Tan, Zheng‐Hua Fang, et al.
Revista Española de Enfermedades Digestivas (2022)
Open Access
Page 1

Scroll to top